海角直播

People with Parkinson海角直播 benefit from new Home-Based Care pathway

Newcastle University creates a pioneering care programme through which people with Parkinson海角直播 are supported in managing and monitoring their condition at home which has shown benefits for patients and care teams.

March 20, 2024: In a breakthrough, researchers from Newcastle University have helped to create a new home-based care pathway for people with Parkinson’s.

The initiative is supported by the Health Foundation and Parkinson海角直播 UK and has been consistently shaped by consultations with individuals living with Parkinson海角直播, their families, and caregivers, ensuring alignment with their needs and priorities. Based on the findings, the team responsible for developing the approach is currently exploring avenues to implement the programme nationally within the NHS, funded by the NHS England海角直播 Digital Health Partnership Award.

Camille Carroll, Professor of Clinical Neuroscience at Newcastle University, who leads the project and serves as the study’s senior author, said: 鈥淭here is currently a significant unmet need for effective and efficiently delivered care for people living with Parkinson海角直播. Through this new care pathway, we have shown the benefits of empowering people with knowledge and understanding of their condition. These benefits are felt not only by the people with Parkinson海角直播 and their partners but also by the healthcare teams and organizations providing their care. With support from NHSE Transformation, we are now creating a digital version of this care pathway, which we hope will eventually enable it to be made available through Parkinson海角直播 services across the UK.鈥

The Home Based Care pathway, introduced in 2019, combines at-home monitoring via wrist-worn sensors with support and information on recognizing and managing various Parkinson海角直播 symptoms. Patients also can reach out to healthcare practitioners for support when needed.

The current study draws from health checks and feedback received from 100 patients undergoing Parkinson海角直播 treatment at the Department of Neurology at University Hospitals Plymouth NHS Trust.

Parkinson海角直播 is the world海角直播 fastest-growing neurological condition, with the number of UK patients projected to reach 170,000 by 2025. Traditional care involves regular, in-person clinical reviews by a movement disorders specialist. However, current NHS challenges are placing increased pressure on these services.

Dr. Rowan Wathes, Associate Director of Policy and Health Strategy at Parkinson海角直播 UK, highlighted the study’s clear indication that the remotely delivered Parkinson’s care pathway is a safe and feasible model, expressing excitement about potential benefits, particularly for those in underserved communities. He said: 鈥淧arkinson海角直播 UK provides grants to projects that aim to improve Parkinson’s health and care services across the UK through the Parkinson海角直播 Excellence Network. We were pleased to award a grant to this project in 2018. The study clearly shows that the remotely delivered Parkinson’s care pathway is a safe and feasible model and we are excited by the potential benefits for people with Parkinson’s, particularly those from underserved communities. We look forward to seeing the work progress including the results of formal comparisons with standard care.鈥

Podcaster and technology writer Rory Cellan-Jones, chairing an Advisory Group focused on the wider implementation of the Home Based Care pathway, emphasized the dissatisfaction of people with Parkinson海角直播 with the current model, proposing a more flexible home-based system that allows contact with healthcare professionals as needed, supported by new technology for a detailed symptom assessment.

The development of the Home Based Care pathway has also involved researchers from the University of Plymouth and the Department of Neurology at University Hospitals Plymouth NHS Trust.

Check Also

Venus Remedies Joins United Nations Global Compact, Reinforcing Commitment to Sustainable Global Healthcare

Bengaluru, May 19, 2025聽鈥 Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven global …